North Growth Management’s Amgen AMGN Stock Holding History

North Growth Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-25,000	Closed	-$6.14M	–	48
2022 Q1	$6.14M	Sell	25,000 -20,000	-44%	-$4.6M	1.13%	38
2021 Q4	$10.2M	Hold	45,000	–	–	1.7%	24
2021 Q3	$9.66M	Hold	45,000	–	–	1.7%	30
2021 Q2	$11M	Hold	45,000	–	–	1.79%	27
2021 Q1	$11.2M	Hold	45,000	–	–	1.99%	22
2020 Q4	$10.4M	Sell	45,000 -4,000	-8%	-$922K	2.12%	20
2020 Q3	$12.4M	Hold	49,000	–	–	2.72%	11
2020 Q2	$11.5M	Sell	49,000 -4,000	-8%	-$913K	2.75%	11
2020 Q1	$10.8M	Sell	53,000 -8,000	-13%	-$1.75M	3.03%	7
2019 Q4	$14.6M	Hold	61,000	–	–	3.28%	8
2019 Q3	$11.7M	Buy	61,000 +1,000	+2%	+$192K	2.83%	12
2019 Q2	$11.1M	Hold	60,000	–	–	2.74%	10
2019 Q1	$11.4M	Hold	60,000	–	–	3.05%	8
2018 Q4	$11.7M	Hold	60,000	–	–	3.27%	8
2018 Q3	$12.5M	Hold	60,000	–	–	3.16%	7
2018 Q2	$11.1M	Hold	60,000	–	–	2.8%	11
2018 Q1	$10.3M	Hold	60,000	–	–	2.64%	14
2017 Q4	$10.5M	Buy	+60,000	New	+$10.6M	2.74%	12

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

North Growth Management's AMGN Position: Q2 2022 in Review

North Growth Management sold out of Amgen (AMGN) in Q2 2022, closing a stake of 25,000 shares — an estimated $6.14M sold.

North Growth Management first reported a position in AMGN in Q4 2017 and held it in 18 quarters. The position peaked at $14.6M in Q4 2019. 2,352 funds tracked by Wall St. Rank hold AMGN as of Q2 2022.

North Growth Management reported no remaining Amgen position as of Q2 2022 after selling out during the quarter.
North Growth Management sold 25,000 Amgen shares in Q2 2022, an estimated $6.14M.
North Growth Management first reported a position in Amgen in Q4 2017 and held it in 18 quarters.
North Growth Management's Amgen position peaked at $14.6M in Q4 2019.
2,352 funds tracked by Wall St. Rank held Amgen as of Q2 2022.

Based on North Growth Management's 13F filing for Q2 2022, filed 18 Jul 2022.